Thursday 28 September 2017

Healthcare Laboratory Informatics Industry Share, Growth, Analysis, Statistics, Trends, Forecast Report, 2024

The medical industry report “Healthcare Laboratory Informatics Market Size By Product (LIMS, ELN, SDMS, CDS, LES), By Deployment (On Premise, Cloud Based), By Component (Services, Software), By End Use (Biotech Companies, Pharmaceuticals, Clinical), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, China, Japan, India, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Development, Price Trend, Competitive Landscape & Forecast, 2017 – 2024”, by Global Market Insights, Inc. says The emergence of digitization and big data analytics is providing a major push to healthcare laboratory informatics market outlook, which is projected to exceed a revenue of USD 1.8 billion by 2024, with 9.5% CAGR projection.

Over the years, the escalating growth of healthcare laboratory informatics market has been highly influenced by the surging requirements of laboratories to comply with a plethora of regulations. The healthcare space that has been witnessing a paradigm shift from volume to value-based model is adding a renewed dynamism to the market. The growing volume and complexity of clinical data are necessitating the requirement of advanced HTS (high throughput screening) and UHTS (Ultra high throughput screening) solutions that can efficiently derive meaningful insights. In addition to this, increasing integration of lab automation in contract manufacturing and research organizations have significantly accelerated healthcare laboratory informatics market commercialization.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/1789

This is quite evident from the increasing adoption rate of cloud computing technology in the healthcare organizations lately. Cloud computing technology enables customized services via internet such as disease monitoring, providing alerts to patients about the risks, and geospatial mapping. Advancement in virtualization and increasing access to high-speed internet at low cost is allowing healthcare organization to readily adapt these advanced technological solutions, leaving a subsequent impact on healthcare laboratory informatics market dynamics.

The renewed healthcare fraternity where cost effective value-based models have become imperative, the industry giants are vigorously exploiting the potential growth prospects of the market. Strategic acquisitions, geographical expansion, and business partnerships are some of the major strategies adopted by the companies to maintain their position in the global healthcare laboratory informatics industry. Leading companies are also integrating informatics solutions to have a competitive edge in the competitive business landscape. Abbott Informatics, Perkin Elmer, Thermo Fisher, Perkin Elmer, LabVantage, LabWare, Lablynx, and Core Informatics are some of the top companies witnessing a strong ground in the overall healthcare laboratory informatics market.

Browse key industry insights spread across 120 pages with 98 market data tables & 15 figures & charts from this 2017 report Healthcare Laboratory Informatics Market in detail along with the table of contents at:


Based on the product trends, LIMS (Laboratory Information Management Systems) dominated the global share in 2016. The prime trigger that is enhancing the LIMS based healthcare laboratory informatics market share is its increasing deployment in biobanks. Increasing proliferation of integrated healthcare solutions that require advanced systems to manage a chain of services such as online request management, data security, regulatory compliance, client billing, and patient demographics have significantly increased healthcare laboratory informatics market demand. Other than LIMS, scientific data management systems are also expected to chart an appreciable growth in the years ahead, with a CAGR projection of 9% over 2017-2024.

Overall, healthcare laboratory informatics market share from services observed a notable surge in 2016, covering almost half of the overall volume. The trend is likely to continue in the same line over the coming years, subject to its low internal IT resource requirement and comparatively lower capital investment.  Software based market will also witness substantial growth, driven by the increasing demand for technologically evolved scientific data integrated software solutions in clinics and hospitals. Having said that, it is imperative to note that clinics will cover a major portion of the healthcare laboratory industry share in the coming seven years. Growing incorporations of laboratory informatics for health information tacking and quality assurance is further fueling the overall industry trend.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1789

Regionally, healthcare laboratory informatics market has spread its wings mainly across China, U.S., and Germany. The expanding healthcare IT industry in these nations remains the common ground for the regional market growth. Germany’s increasing adoption of cost-effective workflow management system has led the country to achieve a global domination in the overall healthcare laboratory informatics market in 2016. China market will also carve a positive growth chart in the years ahead subject to the ongoing research investments undertaken by both private and public agencies along with spreading healthcare awareness.

Laboratories play a pivotal role in the latest healthcare outcome – based business model. Laboratory information coupled with its scientific data integrated solutions have now become a vital component in the healthcare IT. Despite the fact that healthcare laboratory informatics industry is characterized by some of the major challenges such as unavailability of skilled and trained personnel and instructors that might hamper the industry’s growth path, yet the rapid pace of technological developments and its imprint in medical space will bring a revolutionary change in the way healthcare laboratory informatics market has been perceived so far.

Browse Related Reports:

(CTMS) Clinical Trial Management System Market Size By Component (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode (Web, Cloud, On Premise), By End Use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Poland, Russia, China, India, Japan, South Korea, Taiwan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.



Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Wednesday 27 September 2017

Biopreservation Industry Share, Growth, Analysis, Statistics, Trends, Forecast Report, 2024

The global industry report "Biopreservation Market Size By Product (Equipment, Media, Laboratory Information Management System), By Application (Regenerative Medicine, Biobanking, Drug Discovery), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024" by Global Market Insights, Inc. says Biopreservation market is slated to record a double-digit annual growth rate of 13.4% over 2016-2024, with a projected revenue of USD 9.7 billion by 2024.

Integration of modern technologies in food processing to maintain the microbiological food safety standards is pushing biopreservation market globally. The market has been gaining a remarkable traction in the recent years as biopreservation defines an ecological approach that improves the safety and shelf life of the foods. Increasing consumption of precooked foods that are prone to temperature abuse has led to an increase in food related diseases across the world. Statistics depict that morbidity due to foodborne diseases accounts for a major portion. Not only lifestyle diseases, chronic illnesses like cancer, cardiovascular disease, hypertension has opened up new opportunities for biopreservation market growth. Heightening expenditures on medical services, increasing consumers’ disposable incomes, and the growing demand for regenerative medicines have significantly favored the overall biopreservation industry expansion.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/762

The favorable initiations by the government bodies in the form of funds, grants, and financial assistance have significantly accelerated research activities in the health care sector. Growing number of biobanks across the world for the preservation of DNA, stem cells, plasma, and tissue along with the increased acceptance of ART (assisted reproductive technology) is further complementing biopreservation market dynamics. The overall industry share from bio banking dominated the application landscape in 2015 and is anticipated to continue its prominence over 2016-2024. The combined efforts by the renowned regulatory bodies including WHO, FDA, and ISBER for promoting bio preservative facilities have further provided a major impetus to the biopreservation market.

Browse key industry insights spread across 105 pages with 50 market data tables & 6 figures & charts from this 2017 report Biopreservation Market in detail along with the table of contents at:


Asia Pacific market will chart a profitable roadmap from the bio banking sector. Increasing incidence of chronic diseases, spreading awareness about preservation of umbilical cord cells, and the unmet health care needs are the major driving factors thriving the regional biopreservation market. The region’s encouraging projects on biopreservation and bio banking are quite commendable. Some of the prominent organizations who are involved in these programs include Korea Bio-bank Project, Asian Cancer Research Group, China Kadoorie Bio-bank, International Cancer Genome Consortium, and Asian Pharmacoepidemiology Network. With China and India at the growth front, APAC biopreservation market is expected to witness appreciable growth in the coming time frame.  U.S. biopreservation industry is also estimated to attain substantial revenue over the years ahead, having had a dominant position in the global landscape in 2015.

Considering the product landscape, biopreservation equipment market led the industry in 2015, by accounting for almost 80% of the overall share. Growing deployment of biopreservation equipment in health care laboratories and research centers are the factors that can be given the credit for the market expansion. Other products of the market which represents a significant share encompass LIMS (laboratory information management system) and media. Biopreservation media market will also experience steady gains owing to the technical interference in tissue engineering and regenerative medicine. Overall biopreservation market from regenerative medicine is expected to record the highest growth over the coming seven years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/762

Mergers and acquisitions and product renovations are the major strategies adopted by the market players to sustain their position in the market. However, lack of proper regulations and funding with respect to medical data export in some of the geographies is hampering the market penetration in those regions. Nonetheless, the legislations pertaining to this market imposed by some of the renowned organizations like FDA will help biopreservation market to attain a remarkable valuation in the years ahead.

Prominent biopreservation industry participants include Thermo Fisher, Atlanta Biologicals, Lifeline Scientific, VWR International, and Biolife Solutions.


Biomedical Refrigerators And Freezers Market Size By Product (Plasma Freezers, Blood Bank Refrigerators, Lab Refrigerators, Lab Freezers, Ultra Low Temperature Freezers, Shock Freezers), By End use (Blood Banks, Pharmacies, Hospitals, Research Labs, Diagnostic Centers), Industry Analysis Report, Regional Outlook (U.S, Canada, Germany, UK, France, Spain, Italy, Russia, Ukraine, Poland, China, Japan, India, Australia, Malaysia, Indonesia, Thailand, Brazil, Mexico, Argentina, South Africa, UAE, Saudi Arabia, Qatar, Kuwait, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


Biotechnology Market Size By Technology (Fermentation, Tissue Engineering and Regeneration, PCR Technology, Nanobiotechnology, Chromatograpgy, DNA Sequencing, Cell Based Assay), By Application (Biopharmacy, Bioservices, Bioagriculture, Bioindustrial), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, China, India, Japan, South Korea, Brazil, Saudi Arabia), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Tuesday 26 September 2017

Europe clinical laboratory services market set to exceed $62 bn by 2024

Europe clinical laboratory services market size looks set to cross USD 62 billion by 2024.  Rising awareness pertaining to disease prevention through early diagnosis and availability of sophisticated diagnostic tests should stimulate industry growth.  High prevalence of target diseases will present manufacturers with lucrative future growth opportunities in this region.

Global Market Insights, Inc., Worldwide clinical laboratory services market worth USD 196.9 billion in 2015, will register an annual growth rate of 6.4% over the coming seven years.

Ongoing technological advancements in the healthcare infrastructure is drawing a profitable roadmap for Clinical laboratory services market globally. Reportedly, clinical laboratory services cover 80% of the overall medical diagnosis space, claiming a prominent position in the healthcare diagnosis spectrum. The growth of this industry can be attributed to a multitude of factors such as increasing patient awareness regarding their health and importance of early detection of diseases coupled with a noticeable increase in the geriatric population base. Biochips, microarrays, and companion diagnostics are few of the innovative products which are witnessing massive adoption rates across the testing laboratories.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/807

Clinics, standalone laboratories, and hospitals are key service providers in clinical laboratory services market. Standalone laboratories were recognized as the most lucrative service providers and accounted for a revenue of USD 73 billion in 2015. Wide range of test facilities by these labs make it a preferable service provider.  This segment is estimated to register an annual growth rate of 7% over the period of 2016-2024. Hospital based clinical laboratory services market had a revenue of USD 113.4 billion in 2015 and is predicted to record considerable growth rate over the years ahead.

Order This Report by calling Global Market Insights, Inc. at 1-888-689-0688 (Toll Free) or 1-302-846-7766.

The differentiating factor of Clinical Laboratory Services market report by Global Market Insights, Inc. when compared with other, similar syndicated research studies includes a 360-degree synopsis of trends for a period of more than 10 years including historic information as well as future outlook. Business focussed multiple trends for Clinical Laboratory Services industry are discussed along with regional trends to offer an overall view of the market. The ‘industry insights’ chapter of this research provides the most comprehensive analysis of Clinical Laboratory Services market covering segmentation, size, forecasts, ecosystem analysis and more. Industry impact forces (regional and global) that cover growth drivers and challenges, growth potential analysis, a strategy dashboard for competitive landscape of Clinical Laboratory Services market support this sector specific data and information points.

Browse key industry insights spread across 110 pages with 33 market data tables & 10 figures & charts from this 2017 report Clinical Laboratory Services Market in detail along with the table of contents at:

Based on the tests carried out, clinical laboratory services industry is mainly divided into clinical chemistry, other esoteric test, medical microbiology & cytology, and human & tumor genetics. Clinical chemistry test accounted for more than 47% of the market share in 2015 and will collect attractive revenue of more than USD 152 billion by 2024, primarily driven by its surging requirement for the treatment of invasively growing diseases such as blood disorders, diabetes, cardiovascular, and liver & kidney.

Geographically, Europe clinical laboratory services market will surpass a revenue collection of USD 62 billion by 2024. The industry growth can be attributed to the availability of advanced diagnostic test methods along with growing awareness among the people regarding early diagnosis of diseases. UK and Germany collectively accounted for 27% of the regional revenue share.
U.S. clinical laboratory services industry size contributed substantially toward the regional growth by collecting a revenue of USD 64 billion in 2015 and will exhibit considerable growth rate over the period of 2016 to 2024, owing to the surging implementation of advanced diagnostic technologies.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/807
Asia pacific clinical laboratory services market share is anticipated to generate a revenue of more than USD 76 billion by 2024. The presence of a large aging population base across the APAC countries such as China and Japan will augment the high product demand. In addition to this, growing investments in healthcare infrastructure to develop novel and advanced diagnostic devices will also favor the industry growth.
Clinical laboratory services industry is consolidated with top four market players- Sonic Healthcare, Quest Diagnostics, LabCorp, and Genoptix Medical Laboratory having acquired more than 45% of the business space in 2015. Product differentiation, mergers & acquisitions, and regional expansion will be the key growth strategies adopted by the industry giants to sustain their market value.  

(CTMS) Clinical Trial Management System Market Size By Component (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode (Web, Cloud, On Premise), By End Use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Poland, Russia, China, India, Japan, South Korea, Taiwan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

https://www.gminsights.com/industry-analysis/clinical-trial-management-system-ctms-market  

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Monday 25 September 2017

Transfer Cancer Gene Therapy Market share to see growth of 20.9% from 2016 to 2024

The research report “Cancer Gene Therapy Market Size By Type [Gene Induced Immunotherapy (Cytokine Gene Delivery, Tumor Antigen Gene Delivery), Oncolytic Virotherapy (Adenoviruses, Lentiviruses, Retrovirus, Adeno Associated Virus, Herpes Simplex Virus, Alphavirus, Vaccinia Virus, Simian Virus), Gene Transfer/Gene Replacement (Naked/Plasmid Vectors, Electroporation, Sonoporation, Magnetofection, Gene Gun)], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, China, Japan, Mexico, Brazil, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., says Cancer gene therapy industry revenue, which was assessed at USD 805.5 million in 2015, is projected to hit USD 4.3 billion by 2024.

A significant rise in the number of cancer incidences has led to the deployment of genome technologies, which will spur Cancer Gene Therapy Market size. As per WHO estimates, the number of cancer cases is estimated to increase by 70% over the coming two decades, which will stimulate the introduction of new gene therapies. Heavy funding by the government for cancer research programs and beneficial schemes favoring cancer screening programs are expected to produce lucrative avenues for cancer gene therapy market.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/763

The differentiating factor of Cancer Gene Therapy market report by Global Market Insights, Inc. when compared with other, similar syndicated research studies includes a 360-degree synopsis of trends for a period of more than 10 years including historic information as well as future outlook. Business focussed multiple trends for Cancer Gene Therapy industry are discussed along with regional trends to offer an overall view of the market. The ‘industry insights’ chapter of this research provides the most comprehensive analysis of Cancer Gene Therapy market covering segmentation, size, forecasts, ecosystem analysis and more. Industry impact forces (regional and global) that cover growth drivers and challenges, growth potential analysis, a strategy dashboard for competitive landscape of Cancer Gene Therapy market support this sector specific data and information points.

Order This Report by calling Global Market Insights, Inc. at 1-888-689-0688 (Toll Free) or 1-302-846-7766.

Considering the regional trends, cancer gene therapy industry in China, which accounted for 35% of Asia Pacific cancer gene therapy market share in 2015, is projected to record a CAGR of 21% over the next few years, having collected a revenue of USD 99.6 million in 2015. Rapid commercialization of drugs required for cancer gene therapy coupled with enhanced developments in healthcare services will drive the regional expansion. UK cancer gene therapy industry, which was assessed at USD 92 million in 2015, is set to grow at an annual rate of 20.8% over the coming seven years, subject to high frequency of cancer among the nations’ population along with the acceptance of modern treatment methodologies.  Cancer gene therapy market in Japan, worth USD 78.2 million in 2015, is projected to expand at a CAGR of 20.9% over the period from 2016 to 2024.

Browse key industry insights spread across 105 pages with 125 market data tables & 6 figures & charts from this 2017 report Cancer Gene Therapy Market in detail along with the table of contents at:


U.S. cancer gene therapy industry, which contributed more than 95% of North America cancer gene therapy market revenue in 2015, is projected to grow at a rate of 20.9% over the coming seven years. It had amassed an income of USD 235 million in 2015. Innovation in biotechnology and the rising acceptance of new gene technologies for cancer treatments is expected to boost the regional revenue.

Cancer gene therapies comprise gene transfer, oncolytic virotherapy, and gene induced immunotherapy. Gene transfer market size, which accounted for more than 46% of the cancer gene therapy market revenue in 2015, is projected to record a CAGR of 20.9% over the coming timeframe. This therapy helps to permanently alter the nuclear genome of the host cell and is widely deployed across the medical sector, stimulating the overall market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/763

Gene induced immunotherapy industry, which contributed to 14% of cancer gene therapy market share in 2015, is slated to surpass USD 592.7 million by 2024.  The growth can be attributed to its ability to effectively fight cancer cells through new gene insertion in the tumors.

Global cancer gene therapy market is highly fragmented with small biotech firms holding a chunk of the overall industry share. Key business expansion strategies such as deployment of advanced technologies, copyrights & patenting of products, strategic collaborations, and joint ventures adopted by major industry participants will help them in retaining their positions in the global business space.  NewLink Genetics Corporation, ZIOPHARM Oncology Incorporation, Shenzhen Sibiono GeneTech Company Limited, Genelux Corporation, Gradalis Incorporation, Altor Bioscience Corporation, Shanghai Sunway Biotech Company Limited, Amgenen Incorporation, MultiVir Incorporation, Aduro Biotech Incorporation, OncoGeneX Pharmaceuticals Company, GlobeImmune Incorporation, MolMed S.p.A., and BioCancell Therapeutic Incorporation are the few of the established players of cancer gene therapy industry.


Cancer Biological Therapy Market Size By Product (Monoclonal Antibodies [Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bi-Specific Monoclonal Antibodies], Vaccines [Preventive, Therapeutic], Cancer Growth Blockers [Tyrosine Kinase Inhibitors, Proteasome Inhibitors, mTOR Inhibitors], Blood Cell Growth Factors [Lenograstim, Filgrastim], Cytokines [Interferons, Interleukins]), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023


About Global Market Insights"

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Thursday 21 September 2017

Breast Implants industry analysis research and trends report for 2017-2024

The research report “Breast Implants Market Size By Product (Silicone Implant, Saline Implant), By Shape (Round, Anatomical), By Application (Breast Augmentation, Breast Reconstruction), By End Use (Hospitals, Clinics, Others), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, China, India, Japan, South Korea, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024”, by Global Market Insights, Inc. says, Breast Implants Market is estimated to grow at CAGR of 5% from 2017 to 2024.
Over the years, breast implants market has been one of the most burgeoning business spaces, with increasing number of women undergoing noninvasive procedures for breast reconstruction and breast augmentation. This can be evidenced by the recent valuation claimed by the American Society of Plastic Surgeons- which depicts that almost 290,467 breast augmentation procedures have been performed last year in America, a rise of almost 4% from what it recorded in the year 2015.
Request for a sample of this research report @ https://www.fractovia.org/request-sample/630
Undoubtedly, this humongous number is quite a proof that women are still flocking to surgeons to look more healthy, attractive, vibrant, youthful. Like any other business fraternity, technological advancements and modernization have brought forth incredible development in the breast implants market outlook- evidence to the fact is the rising trend of smaller breast implants.
Considering the immense popularity of breast implants in the cosmetic surgery business space, breast implants industry, as claimed by Global Market Insights, Inc., will surpass a valuation of USD 4 billion by the end of 2024. In this regard, it is prudent to mention, that the growth of the overall industry is closely linked with the increasing prevalence of breast cancer. The American Cancer Society estimates that almost 252710 cases of invasive breast cancer will be detected in U.S. in 2017.
Browse key industry insights spread across 95 pages with 118 market data tables & 18 figures & charts from this 2017 report Breast Implants Market in detail along with the table of contents at:
Taking into account the psychological benefits and patient wellbeing, breast reconstruction is often recommended by surgeons post mastectomy. In fact, breast reconstruction accounted for 1.9% of the overall reconstructive procedures in 2016, with a massive increase of 39% from that what it recorded in 2000. This goes without saying that the aforementioned statistics further affirm the commercialization potential of breast implants market in the coming years.
Speaking along the similar lines, the reason behind U.S. to become the hot spot for breast implants industry investors is quite overt- the evolving healthcare infrastructure, increasing occurrence of breast cancer, and the growing spending in cosmetic surgeries. Statistics claim that U.S procured almost 85% of North America breast implants market in 2016.
Make an inquiry for buying this report @ https://www.fractovia.org/request-purchase/630
Looking into the current scenario, it is rather undeniable that U.S. breast implants market will embark on a profitable path in the ensuing years. Silicone implants led the product landscape in 2016, and experts believe, the domination would continue in the coming seven years as well. The technological proliferation has led to a reduction of rippling in breasts, which in a way has proven to be a favorable determinant for the overall breast implants market growth.
Global breast implants industry is considerably characterized by product differentiation and R&D activities. Manufacturers are bringing various refinements and modifications in their models to gain a competitive advantage. For instance, recently, Allergan, a leading name in the breast implants industry, made to the headlines when its breakthrough product, NATRELLE INSPIRA Cohesive breast implant, received FDA approval with regards to its merchandizing. Some of the other renowned names in this business space include GC Aesthetics, Arion Laboratoires, Sientra, HansBiomed, Cereplas, Groupe Sebbin, and Establishment Labs.
Browse Related Reports:
Breastfeeding Accessories Market Size By Product (Breast Milk Bottles, Breast Milk Storage Bags, Sore Nipple Cream, Nursing Pads, Cleaning Products, Nipple Shields, Breast Shells), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, Russia, China, India, Japan, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024
About Fractovia.org:
Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributors.
Contact Us:
Arun Hegde
Corporate Sales, USA
Fractovia.org
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@fractovia.org
Website: https://www.fractovia.org
Connect with us:Facebook|Twitter